NFL player teams with Sanofi on Auvi-Q promo; Judge backs Cubicin in patent fight with Hospira;

@FiercePharma: ICYMI: 20 Highest-Paid Biopharma CEOs of 2012. Feature Reactions? Use #FPexecpay. | Follow @FiercePharma

@EricPFierce: Women sue Apotex over manufacturing issues that led to too many placebos and unexpected pregnancies. More | Follow @EricPFierce

> Former NFL player Jerome "The Bus" Bettis has signed on with Sanofi ($SNY) to promote anaphylaxis awareness and the company's talking epinephrine injection pen, Auvi-Q. Report

> A federal judge refused to toss multidistrict litigation accusing Pfizer's ($PFE) King Pharmaceuticals unit and Mutual Pharmaceutical of conspiring to keep generic versions of the muscle relaxant Skelaxin off the market. Report

> A U.S. federal court backed Cubist's ($CBST) patent protection on its antibiotic Cubicin in the face of a challenge from generics producer Hospira ($HSP). Report

> Pfizer plans to keep 475 jobs in its consumer healthcare business at a New Jersey facility after moving about 400 staffers spun off with its Zoetis animal health business to a new location. Report

> British farmers will be first in line for a new Merck ($MRK) vaccine against Schmallenberg virus, to be used in sheep and cattle. Report

Medical Device News

@FierceMedDev: German cops seize Boston Scientific stents in cutthroat patent fight. More | Follow @FierceMedDev

@MarkHFierce: It's that time of year again: We're seeking nominations for this year's fiercest medical device and Dx companies. Item | Follow @MarkHFierce

 @DamianFierce: Medtronic rode some international sales success to quarterly revenue growth. Article | Follow @DamianFierce

> Medtronic, J&J's Cordis headline EuroPCR 2013. Article

> Interleukin Genetics raises $12M in last-ditch save. DxExtra

> Sequester cuts threaten FDA's access to industry user fees. Story

Biotech News

@FierceBiotech: New special: Top 10 Biotech CEO Pay Packages of 2012 via @RyanMFierce and @EmilyMFierce. Report | Follow @FierceBiotech

@JohnCFierce: Bayer bolsters campaign for PAH drug riociguat with positive long-term data. More | Follow @JohnCFierce

@RyanMFierce: Interviewed Regeneron's Yancopoulos, biotech's highest paid exec in 2012, about promising allergy drug and success recipe. Story | Follow @RyanMFierce

> Novo nabs anti-infectives outfit in $700M buyout. More

> Pfizer picks up the pieces after its armed antibody crashes in PhIII. Article

> Analysts question Teva's blockbuster expectations on drug makeovers. Story

Biotech Research News

 @EmilyMFierce:  | Follow @EmilyMFierce

> Researchers pinpoint protein involved in cancer cell death. Item

> Alnylam reports positive preclinical results for RNAi therapy to treat rare metabolic disease. More

> Drug boosts effectiveness of radiation therapy for brain tumors. Story

> Scientists use cloning method to create embryonic stem cells. Article

Pharma Manufacturing News

> Novartis' Sandoz unit recalls products from U.S., Poland. News

> Chinese drugmaker fights counterfeiting in Africa with SMS technology. More

> Impax brings in big guns to get on top of manufacturing problems. Story

> Apotex sued over problems on contraceptive packaging line. Article

> Gorsky pleads with employees to think quality. More

And Finally... How pill bottles tattle on poor drug-takers. Report

Suggested Articles

The Pharma Lions shortlist for 2019 lives up to its name with just 31 entries making the cut. But it's still good news for the 12 drugmaker finalists.

Pharma companies filed suit Friday to block the new HHS rule that requires drugmakers to put list prices in TV ads.

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.